Financials
- Financial year
- 2025
- Total assets
- €17,578
- Profit
- €12,157
- Solvency
- 60.3%
Dosavi
ActiveSummary
Dosavi has been active since 2025 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €10,591 and a net result of €12,157. Its solvency ranks better than 48% of 20,358 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
Overview
Activity
General medical practice
NACE 86210
1 site
Size
€17,578total assets 2025
- Equity
- €10,591
- Profit
- €12,157
Turnover not published (micro format)
Structure
Accounts 71 days early
Why 96raises riskFounded in 2025lowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 2.73, cash €14,291Figures for financial year 2025 (filed 21-05-2026)Show the evidence
Checked score
Score 2025
96
/ 100
Excellent
Probability in this band: under 0.55%
Financially better than 65% of its sector peers (NACE 86, micro)
Financial strength
Strong
Solvency
85
equity 60.3% of total assets
Liquidity
85
short-term debt 33.6% · cash 81.3%
Profitability
100
return on assets 69.2%
Bankruptcy probability, 12 months
< 0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Credit of up to €1,000 on 30-day terms is acceptable
Liquidity ample (current ratio 2.73, above the usual 1.5; short-term debt: 33.6% and cash: 81.3% of total assets), and 39.7% of the assets are financed with debt and provisions.
How it is calculated
The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 48% on solvency, 68% on liquidity and 80% on profitability.
The bankruptcy probability was computed on 15-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).
Credit check for your own amount and term
Show the recommended maximum and see how the verdict changes with amount, term and advance.
Signals
Five signals.
lowers riskraises riskneutral
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 21-05-2026, 71 days ahead of the deadline.
NBB · 1 filingDeviation from the deadline
2025
71 days early
← before the deadline
after the deadline →
Searched, nothing found (1)
- Annual accounts filedfinancial year 2025 · micro…
- IncorporationAppointment: VITS Sander (niet statutair…
Key points
By topic
Timeline
- Events
- 2
- Since
- 2025
Company details
- Sites
- 1
- Legal form
- Private limited company
- Activity
- General medical practiceNACE 86210
- Founded
- 12-08-2025
- Year ends
- 31-12
- Peppol
- Reachable for e-invoices
Articles of association
- Provisions read
- 37
- Annual meeting
- Last Friday of June at 14:00
- Purpose
- “De uitoefening van de algemene geneeskunde,door de artsen-vennoten,in naam en voor…” (deed in Dutch)
Go further with this company
How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark Roughly what is this company worth?Value indication
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.